{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:40:53Z","timestamp":1776361253532,"version":"3.51.2"},"reference-count":28,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":757,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1111\/apt.12435","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T11:58:46Z","timestamp":1375703926000},"page":"794-803","source":"Crossref","is-referenced-by-count":18,"title":["Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid"],"prefix":"10.1111","volume":"38","author":[{"given":"K. M.","family":"Boberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Wisl\u00f8ff","sequence":"additional","affiliation":[{"name":"Norwegian Knowledge Centre for the Health Services; Oslo; Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. S.","family":"Kj\u00f8llesdal","sequence":"additional","affiliation":[{"name":"Oslo Hospital Service; Oslo University Hospital; Oslo; Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"St\u00f8vring","sequence":"additional","affiliation":[{"name":"Department of Public Health; Aarhus University; Aarhus; Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. S.","family":"Kristiansen","sequence":"additional","affiliation":[{"name":"Department of Health Management and Health Economics; Institute of Health and Society; University of Oslo; Oslo; Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,8,5]]},"reference":[{"key":"10.1111\/apt.12435-BIB0001|apt12435-cit-0001","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","article-title":"Primary biliary cirrhosis","volume":"335","author":"Kaplan","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/apt.12435-BIB0002|apt12435-cit-0002","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12435-BIB0003|apt12435-cit-0003","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"19","author":"Heathcote","year":"1994","journal-title":"Hepatology"},{"key":"10.1111\/apt.12435-BIB0004|apt12435-cit-0004","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis","volume":"106","author":"Lindor","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12435-BIB0005|apt12435-cit-0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","article-title":"Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver","volume":"32","author":"Pares","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12435-BIB0006|apt12435-cit-0006","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","article-title":"Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group","volume":"330","author":"Poupon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1111\/apt.12435-BIB0007|apt12435-cit-0007","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12435-BIB0008|apt12435-cit-0008","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/j.1572-0241.2007.01235.x","article-title":"Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses","volume":"102","author":"Gong","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12435-BIB0009|apt12435-cit-0009","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/apt.12435-BIB0010|apt12435-cit-0010","first-page":"CD000551","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","author":"Gluud","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/apt.12435-BIB0011|apt12435-cit-0011","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1572-0241.2006.00634.x","article-title":"Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials","volume":"101","author":"Shi","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12435-BIB0012|apt12435-cit-0012","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0168-8278(00)80232-9","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past-issues for the future","volume":"32","author":"Poupon","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12435-BIB0013|apt12435-cit-0013","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/apt.12435-BIB0014|apt12435-cit-0014","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"EASL","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12435-BIB0015|apt12435-cit-0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/hep.510290116","article-title":"Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis","volume":"29","author":"Pasha","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/apt.12435-BIB0016|apt12435-cit-0016","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1478-3231.1999.tb00020.x","article-title":"Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid","volume":"19","author":"Angulo","year":"1999","journal-title":"Liver"},{"key":"10.1111\/apt.12435-BIB0017|apt12435-cit-0017","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: a practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med Decis Making"},{"key":"10.1111\/apt.12435-BIB0018|apt12435-cit-0018","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"10.1111\/apt.12435-BIB0019|apt12435-cit-0019","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM199808063390606","article-title":"Gains in life expectancy from medical interventions-standardizing data on outcomes","volume":"339","author":"Wright","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/apt.12435-BIB0020|apt12435-cit-0020","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1053\/gast.1996.v110.pm8613058","article-title":"Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis","volume":"110","author":"Lindor","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12435-BIB0021|apt12435-cit-0021","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12435-BIB0022|apt12435-cit-0022","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0168-8278(99)80136-6","article-title":"Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial","volume":"30","author":"Angulo","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12435-BIB0023|apt12435-cit-0023","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12435-BIB0024|apt12435-cit-0024","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/hep.510230108","article-title":"Time course of histological progression in primary biliary cirrhosis","volume":"23","author":"Locke","year":"1996","journal-title":"Hepatology"},{"key":"10.1111\/apt.12435-BIB0025|apt12435-cit-0025","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/0272989X12455463","article-title":"State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3","volume":"32","author":"Siebert","year":"2012","journal-title":"Med Decis Making"},{"key":"10.1111\/apt.12435-BIB0026|apt12435-cit-0026","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12435-BIB0027|apt12435-cit-0027","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/apt.12435-BIB0028|apt12435-cit-0028","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1089-3261(03)00103-X","article-title":"Primary biliary cirrhosis: specific treatment","volume":"7","author":"Carithers","year":"2003","journal-title":"Clin Liver Dis"}],"container-title":["Alimentary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.12435","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/apt.12435\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T01:23:43Z","timestamp":1715822623000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.12435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,5]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"URL":"https:\/\/doi.org\/10.1111\/apt.12435","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8,5]]}}}